Total Payments
$18,510
2024 Payments
$2,274
Companies
61
Transactions
1,271
Medicare Patients
2,854
Medicare Billing
$212,442
Payment Breakdown by Category
Food & Beverage$18,480 (99.8%)
Education$30.55 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,480 | 1,266 | 99.8% |
| Education | $30.55 | 5 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,773 | 94 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,605 | 111 | $0 (2024) |
| Novo Nordisk Inc | $1,521 | 123 | $0 (2024) |
| ABBVIE INC. | $1,449 | 109 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,439 | 88 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,261 | 77 | $0 (2023) |
| Lilly USA, LLC | $1,213 | 101 | $0 (2024) |
| Amgen Inc. | $757.02 | 44 | $0 (2024) |
| PFIZER INC. | $731.84 | 60 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $665.70 | 40 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,274 | 118 | Abbott Laboratories ($346.73) |
| 2023 | $2,085 | 139 | GlaxoSmithKline, LLC. ($384.15) |
| 2022 | $2,166 | 147 | ABBVIE INC. ($338.97) |
| 2021 | $2,449 | 155 | AbbVie Inc. ($488.65) |
| 2020 | $1,848 | 129 | Allergan, Inc. ($289.99) |
| 2019 | $2,255 | 163 | AstraZeneca Pharmaceuticals LP ($285.15) |
| 2018 | $2,224 | 161 | SANOFI-AVENTIS U.S. LLC ($334.85) |
| 2017 | $3,211 | 259 | AstraZeneca Pharmaceuticals LP ($337.39) |
All Payment Transactions
1,271 individual payment records from CMS Open Payments — Page 1 of 51
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Diabetes Care | ||||||
| 12/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: DIABETES | ||||||
| 12/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: VACCINES | ||||||
| 12/04/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: DIABETES | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.49 | General |
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: VACCINES | ||||||
| 11/06/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $100.55 | General |
| Category: Neuromodulation | ||||||
| 10/28/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: DIABETES | ||||||
| 10/23/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.47 | General |
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Respiratory | ||||||
| 10/08/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $160.06 | General |
| Category: Neuromodulation | ||||||
| 10/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: RESPIRATORY | ||||||
| 09/30/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 09/30/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $2.23 | General |
| Category: CNS Stimulant for ADHD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 663 | 913 | $101,410 | $48,585 |
| 2022 | 14 | 697 | 952 | $124,471 | $59,164 |
| 2021 | 13 | 638 | 929 | $99,800 | $47,142 |
| 2020 | 17 | 856 | 1,300 | $140,394 | $57,552 |
Total Patients
2,854
Total Services
4,094
Medicare Billing
$212,442
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 155 | 155 | $28,675 | $18,707 | 65.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 141 | 197 | $27,580 | $10,398 | 37.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 80 | 99 | $20,394 | $8,290 | 40.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 11 | 13 | $6,981 | $2,669 | 38.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 37 | 37 | $3,922 | $2,658 | 67.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 15 | 15 | $4,020 | $2,332 | 58.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 38 | 38 | $1,596 | $1,102 | 69.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 49 | 78 | $2,808 | $735.99 | 26.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 15 | 15 | $630.00 | $434.85 | 69.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 37 | $1,813 | $333.07 | 18.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 15 | $1,095 | $292.30 | 26.7% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 53 | 82 | $574.00 | $263.22 | 45.9% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 12 | 14 | $462.00 | $226.80 | 49.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 14 | 14 | $756.00 | $134.29 | 17.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 11 | 104 | $104.00 | $9.37 | 9.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 156 | 156 | $28,860 | $19,381 | 67.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 109 | 143 | $29,458 | $12,187 | 41.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 144 | 224 | $31,360 | $12,035 | 38.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 24 | 30 | $16,110 | $6,141 | 38.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 50 | 51 | $5,406 | $3,482 | 64.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 15 | 15 | $4,020 | $2,395 | 59.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 54 | 55 | $2,310 | $1,505 | 65.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 21 | 21 | $1,533 | $630.96 | 41.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 18 | 49 | $2,401 | $419.89 | 17.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 13 | 13 | $546.00 | $356.84 | 65.4% |
About Dr. Gerald Barber, M.D
Dr. Gerald Barber, M.D is a Family Medicine healthcare provider based in Baton Rouge, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1992704969.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gerald Barber, M.D has received a total of $18,510 in payments from pharmaceutical and medical device companies, with $2,274 received in 2024. These payments were reported across 1,271 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($18,480).
As a Medicare-enrolled provider, Barber has provided services to 2,854 Medicare beneficiaries, totaling 4,094 services with total Medicare billing of $212,442. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Baton Rouge, LA
- Active Since 07/20/2005
- Last Updated 01/07/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1992704969
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,011
- FARXIGA (Drug) $976.53
- JARDIANCE (Drug) $868.59
- VRAYLAR (Drug) $797.69
- UBRELVY (Drug) $597.48
- Ozempic (Drug) $539.95
- TOUJEO (Drug) $523.45
- TRULICITY (Drug) $510.01
- TRINTELLIX (Drug) $465.43
- XARELTO (Drug) $455.53
- TRADJENTA (Drug) $399.43
- Victoza (Drug) $381.03
- MOUNJARO (Drug) $337.04
- VYVANSE (Drug) $308.32
- Livalo (Drug) $302.46
- BEVESPI AEROSPHERE (Drug) $302.25
- JANUVIA (Drug) $284.26
- CHANTIX (Drug) $265.72
- Kerendia (Drug) $255.26
- SOLIQUA (Drug) $248.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Baton Rouge
Dr. Susan Julius, Md, MD
Family Medicine — Payments: $177,846
Family Medicine $177,846
Dr. Christine Smith, Md, MD
Family Medicine — Payments: $104,714
Family Medicine $104,714
Myles Jaynes, D.o, D.O
Family Medicine — Payments: $18,709
Family Medicine $18,709
Dr. Stan Mays, M.d, M.D
Family Medicine — Payments: $17,123
Family Medicine $17,123
Dr. Yushen Lee, M.d, M.D
Family Medicine — Payments: $16,906
Family Medicine $16,906
Dr. Donald Carson, D.o, D.O
Family Medicine — Payments: $15,182
Family Medicine $15,182